Immunoblotting demonstrated increasing PIM3 expression in both HuH6 and COA67 with increasing insensitivity to cisplatin (Fig. 3B), indicating that PIM3 expression correlates with cisplatin resistance in hepatoblastoma. Here, PIM3 is linked to hepatoblastoma.